Mazzei Michael purchased $1.0M of BRSP

Mazzei Michael (CEO) purchased 309,113 shares of BrightSpire Capital, Inc. (BRSP) at an average of $3.24 ($3.11–$3.28, $1.00M total) across 2 trades over 2026-11-13 to 2026-11-16.

Original reporting
SEC EDGAR · Mazzei Michael
Published Nov 17, 2026, 1:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 1:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BRSP
Bullish
medium confidence
Mentioned
$BRSP
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BRSPBullishLow
01

Why it matters

The disclosed open-market purchase increases insider ownership, which traders may interpret as confidence, but it does not change the company’s fundamentals in the text provided.

02

Market read

This is a primary insider-buy disclosure that can slightly influence sentiment, but it is unlikely to drive a major repricing without accompanying business updates.

03

What to watch

The filing does not state intent, constraints, or whether the purchase was part of a broader compensation or tax strategy; also, the price range is relatively narrow, suggesting execution around a short window rather than a thesis-driven accumulation.

Relevance 7/10Novelty 6/10Timing: latest SEC Form 4 filed 2026-11-16, covering trades from 2026-11-13 to 2026-11-16

Background

The filing is an SEC Form 4 insider transaction by BrightSpire Capital CEO Mazzei Michael.

Company-level read

Ticker impact

$BRSPBullishMedium confidence
Context

CEO Mazzei Michael bought about 309,113 shares of BrightSpire Capital for roughly $1.0M, per a new SEC Form 4 filing.

Expected impact

Likely limited near-term impact, with any reaction more sentiment-driven than driven by new company fundamentals.

Evidence & confidence

The article is a primary-source Form 4 showing CEO buying, but it does not include guidance, financial results, or a corporate action that would materially reprice the business.

Market effects

No clear sector read-through; this is company-specific insider activity without operational or regulatory developments.

None indicated.

None indicated.

Counterpoint

Insider purchases can be routine liquidity or diversification actions and may not reflect a strong forward view, especially without a 10b5-1 plan context.

Key entities

  • BrightSpire Capital, Inc.

    US-listed company whose CEO filed an insider purchase on SEC Form 4.

  • Mazzei Michael

    CEO and director who purchased shares in two trades totaling about $1.0M.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BRSPMed

BrightSpire Capital Inc (BRSP) (Q3 2026) Earnings Call Highlights: Strong Loan Growth

BrightSpire Capital (BRSP) reported Q3 2026 earnings, highlighting $275M in pending loan maturities, with 80% already listed for sale. The company is diversifying into industrial, hospitality, and retail sectors, with spreads varying. CEO Mike Mazzei expects modest loan growth and plans one more CLO in 2027, aiming for a $3.5B-$3.75B loan book. The company is considering share repurchases but prioritizing liquidity.

$BRSPMed

BrightSpire (BRSP) Q3 2026 Earnings Call Transcript

BrightSpire (BRSP) reported Q3 2026 earnings, highlighting a GAAP net book value of $7.08 per share and undepreciated book value of $7.87 per share. The company noted significant volatility in capital markets, including a 10-year treasury peak of 5.37%. Despite challenges, BrightSpire achieved $272 million in originations, sold an Albertsons investment, and completed its fifth CLO. Management emphasized maintaining liquidity and balance sheet strength amidst market uncertainty.

$BRSPMed

BrightSpire Q3 2026 slides: loan growth continues, book value dips

BrightSpire Capital (NYSE:BRSP) reported Q3 2026 earnings with adjusted distributable earnings of $0.14 per share, matching expectations. Loan portfolio grew to $3.1B, but book value dipped due to credit quality pressures. Stock rose 2.02% post-report to $3.795. Management highlighted strong loan origination and asset sales, including a $300M industrial asset sale. Credit metrics showed mixed trends with increased watch list and CECL reserves.

$BRSPMed

BrightSpire Capital, Inc. Announces Third Quarter 2026 Financial Results

BrightSpire Capital, Inc. (BRSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 BrightSpire Capital, Inc. Announces Third Quarter 2026 Financial Results NEW YORK, October 27, 2026 – BrightSpire Capital, Inc. (NYSE: BRSP) (“BrightSpire Capital” or the “Company”) today announced its financial results for the third quarter 2026 and certain updates.

$BRSPMedAI 9/10

BrightSpire Capital (BRSP) Prices $960 Million Financing Deal. Can Lending Returns Improve?

BrightSpire Capital (BRSP) priced a $960M commercial real estate CLO, set to close October 16. The deal includes 29 mortgages secured by 38 properties, with $844.8M in investment-grade securities. The weighted-average coupon is Term SOFR plus 1.54%. BRSP plans to redeem its BRSP 2024-FL2 securitization on October 19. The transaction aims to improve funding efficiency and flexibility, but risks include credit exposure and floating-rate mortgage challenges.